Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 614014, 14 pages
http://dx.doi.org/10.1155/2014/614014
Review Article

The Double-Edged Sword in Pathogenic Trypanosomatids: The Pivotal Role of Mitochondria in Oxidative Stress and Bioenergetics

Laboratório de Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brasil 4365, 21040-360 Manguinhos, RJ, Brazil

Received 3 December 2013; Accepted 17 February 2014; Published 31 March 2014

Academic Editor: Wanderley de Souza

Copyright © 2014 Rubem Figueiredo Sadok Menna-Barreto and Solange Lisboa de Castro. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Neglected tropical diseases,” 2013, http://www.who.int/neglected_diseases/en/.
  2. W. de Souza, “Special organelles of some pathogenic protozoa,” Parasitology Research, vol. 88, no. 12, pp. 1013–1025, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Hannaert, F. Bringaud, F. R. Opperdoes, and P. A. M. Michels, “Evolution of energy metabolism and its compartmentation in Kinetoplastida,” Kinetoplastid Biology and Disease, vol. 2, article 11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Docampo, W. de Souza, K. Miranda, P. Rohloff, and S. N. J. Moreno, “Acidocalcisomes—conserved from bacteria to man,” Nature Reviews Microbiology, vol. 3, no. 3, pp. 251–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Schneider, “Unique aspects of mitochondrial biogenesis in trypanosomatids,” International Journal for Parasitology, vol. 31, no. 13, pp. 1403–1415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. WHO, 2013, http://www.who.int/trypanosomiasis_african/en/.
  7. P. G. Kennedy, “Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness),” Lancet Neurology, vol. 12, no. 2, pp. 186–194, 2013. View at Google Scholar
  8. R. Brun, R. Don, R. T. Jacobs, M. Z. Wang, and M. P. Barrett, “Development of novel drugs for human African trypanosomiasis,” Future Microbiology, vol. 6, no. 6, pp. 677–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Rassi Júnior, A. Rassi, and J. M. Rezende, “American trypanosomiasis (Chagas disease),” Infectious Disease Clinics in North America, vol. 26, no. 2, pp. 275–291, 2012. View at Google Scholar
  10. C. J. Schofield, J. Jannin, and R. Salvatella, “The future of Chagas disease control,” Trends in Parasitology, vol. 22, no. 12, pp. 583–588, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. A. Schmunis and Z. E. Yadon, “Chagas disease: a Latin American health problem becoming a world health problem,” Acta Tropica, vol. 115, no. 1-2, pp. 14–21, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Rassi Jr., A. Rassi, and J. A. Marin-Neto, “Chagas disease,” The Lancet, vol. 375, no. 9723, pp. 1388–1402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. N. C. Soeiro and S. L. de Castro, “Screening of potential anti-Trypanosoma cruzi candidates: in vitro and in vivo studies,” Open Medicinal Chemistry Journal, vol. 5, no. 1, pp. 21–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. WHO, “Global report for research on infectious diseases of poverty,” 2012, http://whqlibdoc.who.int/publications/2012/9789241564489_eng.pdf.
  15. M. P. Barrett and S. L. Croft, “Management of trypanosomiasis and leishmaniasis,” British Medical Bulletin, vol. 104, pp. 175–196, 2012. View at Google Scholar
  16. S. L. Croft and P. Olliaro, “Leishmaniasis chemotherapy-challenges and opportunities,” Clinical Microbiology and Infection, vol. 17, no. 10, pp. 1478–1483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sundar and A. Singh, “What steps can be taken to counter the increasing failure of miltefosine to treat visceral leishmaniasis?” Expert Review of Anti-Infective Therapy, vol. 11, no. 2, pp. 117–119, 2013. View at Google Scholar
  18. M. R. Duchen, “Mitochondria and calcium: from cell signalling to cell death,” Journal of Physiology, vol. 529, no. 1, pp. 57–68, 2000. View at Google Scholar · View at Scopus
  19. P. Kakkar and B. K. Singh, “Mitochondria: a hub of redox activities and cellular distress control,” Molecular and Cellular Biochemistry, vol. 305, no. 1-2, pp. 235–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Galluzzi, O. Kepp, C. Trojel-Hansen, and G. Kroemer, “Mitochondrial control of cellular life, stress, and death,” Circulation Research, vol. 111, no. 9, pp. 1198–1207, 2012. View at Google Scholar
  21. L. D. Osellame, T. S. Blacker, and M. R. Duchen, “Cellular and molecular mechanisms of mitochondrial function,” Best Practice & Research Clinical Endocrinology & Metabolism, vol. 26, no. 6, pp. 711–723, 2012. View at Google Scholar
  22. M. F. Bauer, S. Hofmann, W. Neupert, and M. Brunner, “Protein translocation into mitochondria: the role of TIM complexes,” Trends in Cell Biology, vol. 10, no. 1, pp. 25–31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Alberts, A. Johnson, J. Lewis et al., Molecular Biology of the Cell, Garland Science, New York, NY, USA, 5th edition, 2007.
  24. L. Ravagnan, T. Roumier, and G. Kroemer, “Mitochondria, the killer organelles and their weapons,” Journal of Cellular Physiology, vol. 192, no. 2, pp. 131–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kubli and B. Å. Gustafsson, “Mitochondria and mitophagy: the yin and yang of cell death control,” Circulation Researchno, vol. 111, no. 9, pp. 1208–1221, 2012. View at Google Scholar
  26. L. Simpson, “The kinetoplast of the hernoflagellates,” International Review of Cytology, vol. 32, pp. 139–207, 1972. View at Publisher · View at Google Scholar · View at Scopus
  27. J. J. Paulin, “The chondriome of selected trypanosomatids. A three-dimensional study based on serial thick sections and high voltage electron microscopy,” Journal of Cell Biology, vol. 66, no. 2, pp. 404–413, 1975. View at Google Scholar · View at Scopus
  28. L. B. Newberry and J. J. Paulin, “Reconstruction of the chondriome of the amastigote from Trypanosoma cruzi,” Journal of Parasitology, vol. 75, no. 4, pp. 649–652, 1989. View at Google Scholar · View at Scopus
  29. W. de Souza, M. Attias, and J. C. F. Rodrigues, “Particularities of mitochondrial structure in parasitic protists (Apicomplexa and Kinetoplastida),” The International Journal of Biochemistry & Cell Biology, vol. 41, no. 10, pp. 2069–2080, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. M. Fidalgo and L. Gille, “Mitochondria and trypanosomatids: targets and drugs,” Pharmaceutical Research, vol. 28, no. 11, pp. 2758–2770, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Griparic and A. M. van der Bliek, “The many shapes of mitochondrial membranes,” Traffic, vol. 2, no. 4, pp. 235–244, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Duszenko, M. L. Ginger, A. Brennand et al., “Autophagy in protists,” Autophagy, vol. 7, no. 2, pp. 127–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. G. W. Morgan, D. Goulding, and M. C. Field, “The single dynamin-like protein of Trypanosoma brucei regulates mitochondrial division and is not required for endocytosis,” The Journal of Biological Chemistry, vol. 279, no. 11, pp. 10692–10701, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Schneider, D. Bursać, and T. Lithgow, “The direct route: a simplified pathway for protein import into the mitochondrion of trypanosomes,” Trends in Cell Biology, vol. 18, no. 1, pp. 12–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Pusnik, J. Mani, O. Schmidt et al., “An essential novel component of the noncanonical mitochondrial outer membrane protein import system of trypanosomatids,” Molecular Biology of the Cell, vol. 23, no. 17, pp. 3420–3428, 2012. View at Google Scholar
  36. M. R. Duncan, M. Fullerton, and M. Chaudhuri, “Tim50 in Trypanosoma brucei possesses a dual specificity phosphatase activity and is critical for mitochondrial protein import,” The Journal of Biological Chemistry, vol. 288, no. 5, pp. 3184–3197, 2013. View at Google Scholar
  37. M. Pusnik, O. Schmidt, A. J. Perry et al., “Mitochondrial preprotein translocase of trypanosomatids has a bacterial origin,” Current Biology, vol. 21, no. 20, pp. 1738–1743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. A. Shapiro and P. T. Englund, “The structure and replication of kinetoplast DNA,” Annual Review of Microbiology, vol. 49, pp. 117–143, 1995. View at Google Scholar · View at Scopus
  39. R. E. Jensen and A. E. Johnson, “Opening the door to mitochondrial protein import,” Nature Structural Biology, vol. 8, no. 12, pp. 1008–1010, 2001. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Niemann, S. Wiese, J. Mani et al., “Mitochondrial outer membrane proteome of Trypanosoma brucei reveals novel factors required to maintain mitochondrial morphology,” Molecular and Cellular Proteomics, vol. 12, no. 2, pp. 515–528, 2013. View at Google Scholar
  41. B. Liu, Y. Liu, S. A. Motyka, E. E. C. Agbo, and P. T. Englund, “Fellowship of the rings: the replication of kinetoplast DNA,” Trends in Parasitology, vol. 21, no. 8, pp. 363–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Hong and L. Simpson, “Genomic organization of Trypanosoma brucei kinetoplast DNA minicircles,” Protist, vol. 154, no. 2, pp. 265–279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Woodward and K. Gull, “Timing of nuclear and kinetoplast DNA replication and early morphological events in the cell cycle of Trypanosoma brucei,” Journal of Cell Science, vol. 95, no. 1, pp. 49–57, 1990. View at Google Scholar · View at Scopus
  44. J. C. Hines and D. S. Ray, “Structure of discontinuities in kinetoplast DNA-associated minicircles during S phase in Crithidia fasciculata,” Nucleic Acids Research, vol. 36, no. 2, pp. 444–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. C. E. Clayton and P. Michels, “Metabolic compartmentation in African trypanosomes,” Parasitology Today, vol. 12, no. 12, pp. 465–471, 1996. View at Publisher · View at Google Scholar · View at Scopus
  46. A. G. Tielens and J. J. Van Hellemond, “Differences in energy metabolism between Trypanosomatidae,” Parasitology Today, vol. 14, no. 7, pp. 265–271, 1998. View at Publisher · View at Google Scholar · View at Scopus
  47. R. L. S. Gonçalves, R. F. S. Menna Barreto, C. R. Polycarpo, F. R. Gadelha, S. L. Castro, and M. F. Oliveira, “A comparative assessment of mitochondrial function in epimastigotes and bloodstream trypomastigotes of Trypanosoma cruzi,” Journal of Bioenergetics and Biomembranes, vol. 43, no. 6, pp. 651–661, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Chance and G. R. Williams, “The respiratory chain and oxidative phosphorylation,” Advances in Enzymology and Related Subjects of Biochemistry, vol. 17, pp. 65–134, 1956. View at Google Scholar · View at Scopus
  49. H. Schägger, “Respiratory chain supercomplexes,” IUBMB Life, vol. 52, no. 3–5, pp. 119–128, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. J. W. Priest and S. L. Hajduk, “Developmental regulation of Trypanosoma brucei cytochrome c reductase during bloodstream to procyclic differentiation,” Molecular and Biochemical Parasitology, vol. 65, no. 2, pp. 291–304, 1994. View at Publisher · View at Google Scholar · View at Scopus
  51. D. P. Nolan and H. P. Voorheis, “The mitochondrion in bloodstream forms of Trypanosoma brucei is energized by the electrogenic pumping of protons catalysed by the F1F0-ATPase,” European Journal of Biochemistry, vol. 209, no. 1, pp. 207–216, 1992. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Denicola-Seoane, H. Rubbo, E. Prodanov, and J. F. Turrens, “Succinate-dependent metabolism in Trypanosoma cruzi epimastigotes,” Molecular and Biochemical Parasitology, vol. 54, no. 1, pp. 43–50, 1992. View at Publisher · View at Google Scholar · View at Scopus
  53. A. G. M. Tielens and J. J. van Hellemond, “Surprising variety in energy metabolism within Trypanosomatidae,” Trends in Parasitology, vol. 25, no. 10, pp. 482–490, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. E. Vercesi, C. F. Bernardes, M. E. Hoffmann, F. R. Gadelha, and R. Docampo, “Digitonin permeabilization does not affect mitochondrial function and allows the determination of the mitochondrial membrane potential of Trypanosoma cruzi in situ,” The Journal of Biological Chemistry, vol. 266, no. 22, pp. 14431–14434, 1991. View at Google Scholar · View at Scopus
  55. G. C. Hill, “Electron transport systems in kinetoplastida,” Biochimica et Biophysica Acta, vol. 456, no. 2, pp. 149–193, 1976. View at Google Scholar · View at Scopus
  56. F. R. Opperdoes and P. A. M. Michels, “Complex I of Trypanosomatidae: does it exist?” Trends in Parasitology, vol. 24, no. 7, pp. 310–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. R. Hernandez and J. F. Turrens, “Rotenone at high concentrations inhibits NADH-fumarate reductase and the mitochondrial respiratory chain of Trypanosoma brucei and T. cruzi,” Molecular and Biochemical Parasitology, vol. 93, no. 1, pp. 135–137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. J. César Carranza, A. J. Kowaltowski, M. A. G. Mendonça, T. C. De Oliveira, F. R. Gadelha, and B. Zingales, “Mitochondrial bioenergetics and redox state are unaltered in Trypanosoma cruzi isolates with compromised mitochondrial complex i subunit genes,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 3, pp. 299–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. T. Shiba, Y. Kido, K. Sakamoto et al., “Structure of the trypanosome cyanide-insensitive alternative oxidase,” Proceedings of the National Academy of Sciences USA, vol. 110, no. 12, pp. 4580–4585, 2013. View at Google Scholar
  60. M. Chaudhuri, R. D. Ott, and G. C. Hill, “Trypanosome alternative oxidase: from molecule to function,” Trends in Parasitology, vol. 22, no. 10, pp. 484–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. K. R. Santhamma and A. Bhaduri, “Characterization of the respiratory chain of Leishmania donovani promastigotes,” Molecular and Biochemical Parasitology, vol. 75, no. 1, pp. 43–53, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Tomás and H. Castro, “Redox metabolism in mitochondria of trypanosomatids,” Antioxidants & Redox Signaling, vol. 19, no. 7, pp. 696–707, 2013. View at Google Scholar
  63. A. Boveris and A. O. M. Stoppani, “Hydrogen peroxide generation in Trypanosoma cruzi,” Experientia, vol. 33, no. 10, pp. 1306–1308, 1977. View at Google Scholar · View at Scopus
  64. P. S. Brookes, A.-L. Levonen, S. Shiva, P. Sarti, and V. M. Darley-Usmar, “Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species,” Free Radical Biology & Medicine, vol. 33, no. 6, pp. 755–764, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. J. F. Turrens, “Oxidative stress and antioxidant defenses: a target for the treatment of diseases caused by parasitic protozoa,” Molecular Aspects of Medicine, vol. 25, no. 1-2, pp. 211–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Fang and D. S. Beattie, “Rotenone-insensitive NADH dehydrogenase is a potential source of superoxide in procyclic Trypanosoma brucei mitochondria,” Molecular and Biochemical Parasitology, vol. 123, no. 2, pp. 135–142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. A. Mehta and C. Shaha, “Apoptotic death in Leishmania donovani promastigotes in response to respiratory chain inhibition: complex II inhibition results in increased pentamidine cytotoxicity,” The Journal of Biological Chemistry, vol. 279, no. 12, pp. 11798–11813, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Fang and D. S. Beattie, “Alternative oxidase present in procyclic Trypanosoma brucei may act to lower the mitochondrial production of superoxide,” Archives of Biochemistry and Biophysics, vol. 414, no. 2, pp. 294–302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. S. R. Wilkinson, S. R. Prathalingam, M. C. Taylor, A. Ahmed, D. Horn, and J. M. Kelly, “Functional characterisation of the iron superoxide dismutase gene repertoire in Trypanosoma brucei,” Free Radical Biology & Medicine, vol. 40, no. 2, pp. 198–209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Ghosh, S. Goswami, and S. Adhya, “Role of superoxide dismutase in survival of Leishmania within the macrophage,” Biochemical Journal, vol. 369, no. 3, pp. 447–452, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. J. A. Atwood III, D. B. Weatherly, T. A. Minning et al., “The Trypanosoma cruzi proteome,” Science, vol. 309, no. 5733, pp. 473–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. L. R. Krauth-Siegel, M. A. Comini, and T. Schlecker, “The trypanothione system,” Subcellular Biochemistry, vol. 44, pp. 231–251, 2007. View at Google Scholar · View at Scopus
  73. F. B. Nogueira, J. C. Ruiz, C. Robello, A. J. Romanha, and S. M. F. Murta, “Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole,” Parasitology Research, vol. 104, no. 4, pp. 835–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  74. R. D. Pearson and R. T. Steigbigel, “Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes,” Journal of Immunology, vol. 127, no. 4, pp. 1438–1443, 1981. View at Google Scholar · View at Scopus
  75. L. Piacenza, G. Peluffo, M. N. Alvarez, A. Martínez, and R. Radi, “Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease,” Antioxidants & Redox Signaling, vol. 19, no. 7, pp. 723–734, 2013. View at Google Scholar
  76. N. P. D. A. Nogueira, C. F. de Souza, F. M. D. S. Saraiva et al., “Heme-induced ROS in Trypanosoma cruzi activates CaMKII-like that triggers epimastigote proliferation. One helpful effect of ROS,” PloS One, vol. 6, no. 10, Article ID e25935, 2011. View at Google Scholar · View at Scopus
  77. J. C. F. Rodrigues, S. H. Seabra, and W. de Souza, “Apoptosis-like death in parasitic protozoa,” Brazilian Journal of Morphological Sciences, vol. 23, no. 1, pp. 87–98, 2006. View at Google Scholar
  78. U. Fischer, R. U. Jänicke, and K. Schulze-Osthoff, “Many cuts to ruin: a comprehensive update of caspase substrates,” Cell Death & Differentiation, vol. 10, no. 1, pp. 76–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. B. Meslin, H. Zalila, N. Fasel, S. Picot, and A.-L. Bienvenu, “Are protozoan metacaspases potential parasite killers?” Parasites and Vectors, vol. 4, no. 1, article 26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. W. R. Proto, G. H. Coombs, and J. C. Mottram, “Cell death in parasitic protozoa: regulated or incidental?” Nature Reviews Microbiology, vol. 11, no. 1, pp. 58–66, 2013. View at Google Scholar
  81. M. Laverrière, J. J. Cazzulo, and V. E. Alvarez, “Antagonic activities of Trypanosoma cruzi metacaspases affect the balance between cell proliferation, death and differentiation,” Cell Death & Differentiation, vol. 19, no. 8, pp. 1358–1369, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. R. F. S. Menna-Barreto, J. R. Corrêa, A. V. Pinto, M. J. Soares, and S. L. De Castro, “Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from β-lapachone,” Parasitology Research, vol. 101, no. 4, pp. 895–905, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. R. F. S. Menna-Barreto, K. Salomão, A. P. Dantas et al., “Different cell death pathways induced by drugs in Trypanosoma cruzi: an ultrastructural study,” Micron, vol. 40, no. 2, pp. 157–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  84. R. F. S. Menna-Barreto, J. R. Corrêa, C. M. Cascabulho et al., “Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi,” Parasitology, vol. 136, no. 5, pp. 499–510, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. L. Piacenza, F. Irigoín, M. N. Alvarez et al., “Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression,” Biochemical Journal, vol. 403, no. 2, pp. 323–334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. G. Sudhandiran and C. Shaha, “Antimonial-induced increase in intracellular Ca2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes,” The Journal of Biological Chemistry, vol. 278, no. 27, pp. 25120–25132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Tsuda, W. H. Witola, K. Ohashi, and M. Onuma, “Expression of alternative oxidase inhibits programmed cell death-like phenomenon in bloodstream form of Trypanosoma brucei rhodesiense,” Parasitology International, vol. 54, no. 4, pp. 243–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  88. R. F. Menna-Barreto and J. Perales, “The expected outcome of the Trypanosoma cruzi proteomic map: a review of its potential biological applications for drug target discovery,” Subcellular Biochemistry, vol. 74, pp. 305–322, 2014. View at Publisher · View at Google Scholar
  89. F. B. Holetz, L. R. Alves, C. M. Probst et al., “Protein and mRNA content of TcDHH1-containing mRNPs in Trypanosoma cruzi,” The FEBS Journal, vol. 277, no. 16, pp. 3415–3426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Cuervo, G. B. Domont, and J. B. De Jesus, “Proteomics of trypanosomatids of human medical importance,” Journal of Proteomics, vol. 73, no. 5, pp. 845–867, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Ferella, D. Nilsson, H. Darban et al., “Proteomics in Trypanosoma cruzi-localization of novel proteins to various organelles,” Proteomics, vol. 8, no. 13, pp. 2735–2749, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. A. K. Panigrahi, T. E. Allen, K. Stuart, P. A. Haynes, and S. P. Gygi, “Mass spectrometric analysis of the editosome and other multiprotein complexes in Trypanosoma brucei,” Journal of the American Society for Mass Spectrometry, vol. 14, no. 7, pp. 728–735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. A. K. Panigrahi, Y. Ogata, A. Zíková et al., “A comprehensive analysis of Trypanosoma brucei mitochondrial proteome,” Proteomics, vol. 9, no. 2, pp. 434–450, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Vertommen, J. Van Roy, J.-P. Szikora, M. H. Rider, P. A. M. Michels, and F. R. Opperdoes, “Differential expression of glycosomal and mitochondrial proteins in the two major life-cycle stages of Trypanosoma brucei,” Molecular and Biochemical Parasitology, vol. 158, no. 2, pp. 189–201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. A. K. Panigrahi, A. Zíková, R. A. Dalley et al., “Mitochondrial complexes in Trypanosoma brucei: a novel complex and a unique oxidoreductase complex,” Molecular and Cellular Proteomics, vol. 7, no. 3, pp. 534–545, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. A. Zíková, A. K. Panigrahi, R. A. Dalley et al., “Trypanosoma brucei mitochondrial ribosomes: affinity purification and component identification by mass spectrometry,” Molecular and Cellular Proteomics, vol. 7, no. 11, pp. 1286–1296, 2008. View at Google Scholar
  97. R. F. S. Menna-Barreto, A. Henriques-Pons, A. V. Pinto, J. A. Morgado-Diaz, M. J. Soares, and S. L. De Castro, “Effect of a β-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles,” Journal of Antimicrobial Chemotherapy, vol. 56, no. 6, pp. 1034–1041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. R. F. S. Menna-Barreto, D. G. Beghini, A. T. S. Ferreira, A. V. Pinto, S. L. De Castro, and J. Perales, “A proteomic analysis of the mechanism of action of naphthoimidazoles in Trypanosoma cruzi epimastigotes in vitro,” Journal of Proteomics, vol. 73, no. 12, pp. 2306–2315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  99. H. M. Andrade, S. M. F. Murta, A. Chapeaurouge, J. Perales, P. Nirdé, and A. J. Romanha, “Proteomic analysis of Trypanosoma cruzi resistance to benznidazole,” Journal of Proteome Research, vol. 7, no. 6, pp. 2357–2367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. D. G. Beghini, A. T. S. Ferreira, V. C. de Almeida et al., “New insights in Trypanosoma cruzi proteomic map: further post-translational modifications and potential drug targets in Y strain epimastigotes,” Journal of Integrated Omics, vol. 2, pp. 106–113, 2012. View at Publisher · View at Google Scholar
  101. M. Hide, A. S. Ritleng, J. P. Brizard, A. Monte-Allegre, and D. Sereno, “Leishmania infantum: tuning digitonin fractionation for comparative proteomic of the mitochondrial protein content,” Parasitology Research, vol. 103, no. 4, pp. 989–992, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Rosenzweig, D. Smith, F. Opperdoes, S. Stern, R. W. Olafson, and D. Zilberstein, “Retooling Leishmania metabolism: from sand fly gut to human macrophage,” The FASEB Journal, vol. 22, no. 2, pp. 590–602, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. M. P. Barrett, J. C. Mottram, and G. H. Coombs, “Recent advances in identifying and validating drug targets in trypanosomes and leishmanias,” Trends in Microbiology, vol. 7, no. 2, pp. 82–88, 1999. View at Publisher · View at Google Scholar · View at Scopus
  104. T. M. Silva, E. F. Peloso, S. C. Vitor, L. H. G. Ribeiro, and F. R. Gadelha, “O2 consumption rates along the growth curve: new insights into Trypanosoma cruzi mitochondrial respiratory chain,” Journal of Bioenergetics and Biomembranes, vol. 43, no. 4, pp. 409–417, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. N. Sen and H. K. Majumder, “Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon,” Current Pharmaceutical Design, vol. 14, no. 9, pp. 839–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. J. C. F. Rodrigues and W. de Souza, “Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitos,” Current Pharmaceutical Design, vol. 14, no. 9, pp. 925–938, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. M. A. Vannier-Santos and S. L. De Castro, “Electron microscopy in antiparasitic chemotherapy: a (close) view to a kill,” Current Drug Targets, vol. 10, no. 3, pp. 246–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  108. K. Lazardi, J. A. Urbina, and W. de Souza, “Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 11, pp. 2097–2105, 1990. View at Google Scholar · View at Scopus
  109. M. A. Vannier-Santos, J. A. Urbina, A. Martiny, A. Neves, and W. de Souza, “Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania,” The Journal of Eukaryotic Microbiology, vol. 42, no. 4, pp. 337–346, 1995. View at Google Scholar · View at Scopus
  110. J. C. F. Rodrigues, C. F. Bernardes, G. Visbal, J. A. Urbina, A. E. Vercesi, and W. de Souza, “Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition,” Protist, vol. 158, no. 4, pp. 447–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  111. S. T. Macedo-Silva, J. A. Urbina, W. de Souza, and J. C. Rodrigues, “In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis,” PLoS One, vol. 8, no. 12, Article ID e83247, 2013. View at Google Scholar
  112. G. Pérez-Moreno, M. Sealey-Cardona, C. Rodrigues-Poveda et al., “Endogenous sterol biosynthesis is important for mitochondrial function and cell morphology in procyclic forms of Trypanosoma brucei,” International Journal of Parasitology, vol. 42, no. 11, pp. 975–989, 2012. View at Google Scholar
  113. R. M. Santa-Rita, R. Lira, H. S. Barbosa, J. A. Urbina, and S. L. de Castro, “Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis,” Journal of Antimicrobial Chemotherapy, vol. 55, no. 5, pp. 780–784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  114. C. O. Rodrigues, R. Catisti, S. A. Uyemura et al., “The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin-permeabilization,” Journal of Eukaryotic Microbiology, vol. 48, no. 5, pp. 588–594, 2001. View at Google Scholar · View at Scopus
  115. J. A. Urbina, “Ergosterol biosynthesis and drug development for Chagas disease,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 1, pp. 311–318, 2009. View at Google Scholar · View at Scopus
  116. R. Docampo, F. R. Gadelha, S. N. Moreno, G. Benaim, M. E. Hoffmann, and A. E. Vercesi, “Disruption of Ca2+ homeostasis in Trypanosoma cruzi by crystal violet,” The Journal of Eukaryotic Microbiology, vol. 40, no. 3, pp. 311–316, 1993. View at Google Scholar · View at Scopus
  117. M. C. M. Motta, “Kinetoplast as a potential chemotherapeutic target of trypanosomatids,” Current Pharmaceutical Design, vol. 14, no. 9, pp. 847–854, 2008. View at Publisher · View at Google Scholar · View at Scopus
  118. M. N. Soeiro, S. L. de Castro, E. M. de Souza, D. G. Batista, C. F. Silva, and D. W. Boykin, “Diamidine activity against trypanosomes: the state of the art,” Current Molecular Pharmacology, vol. 1, no. 2, pp. 151–161, 2008. View at Google Scholar · View at Scopus
  119. C. F. Silva, M. B. Meuser, E. M. de Souza et al., “Cellular effects of reversed amidines on Trypanosoma cruzi,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 11, pp. 3803–3809, 2007. View at Publisher · View at Google Scholar · View at Scopus
  120. D. D. G. J. Batista, M. M. Batista, G. M. De Oliveira et al., “Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 7, pp. 2940–2952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. A. Schnaufer, G. J. Domingo, and K. Stuart, “Natural and induced dyskinetoplastic trypanosomatids: how to live without mitochondrial DNA,” International Journal for Parasitology, vol. 32, no. 9, pp. 1071–1084, 2002. View at Publisher · View at Google Scholar · View at Scopus
  122. R. E. Jensen and P. T. Englund, “Network news: the replication of kinetoplast DNA,” Annual Review of Microbiology, vol. 66, pp. 473–491, 2012. View at Google Scholar
  123. A. Roy Chowdhury, R. Bakshi, J. Wang et al., “The killing of African trypanosomes by ethidium bromide,” PLoS Pathogens, vol. 6, no. 12, Article ID e1001226, 2010. View at Google Scholar · View at Scopus
  124. T. A. Shapiro and A. F. Showalter, “In vivo inhibition of trypanosome mitochondrial topoisomerase II: effects on kinetoplast DNA maxicircles,” Molecular and Cellular Biology, vol. 14, no. 9, pp. 5891–5897, 1994. View at Google Scholar · View at Scopus
  125. R. Díaz-González, Y. Pérez-Pertejo, C. F. Prada, C. Fernández-Rubio, R. Balaña-Fouce, and R. M. Reguera, “Novel findings on trypanosomatid chemotherapy using DNA topoisomerase inhibitors,” Mini Reviews in Medicinal Chemistry, vol. 9, no. 6, pp. 674–676, 2009. View at Google Scholar
  126. G. F. Riou, M. Gabillot, S. Douc-Rasy, A. Kayser, and M. Barrois, “A type I DNA topoisomerase from Trypanosoma cruzi,” European Journal of Biochemistry, vol. 134, no. 3, pp. 479–484, 1983. View at Google Scholar · View at Scopus
  127. A. Das, A. Dasgupta, T. Sengupta, and H. K. Majumder, “Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets,” Trends in Parasitology, vol. 20, no. 8, pp. 381–387, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. A. L. Bodley, A. K. Chakraborty, S. Xie, C. Burri, and T. A. Shapiro, “An unusual type IB topoisomerase from African trypanosomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7539–7544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  129. S. P. Fragoso and S. Goldenberg, “Cloning and characterization of the gene encoding Trypanosoma cruzi DNA topoisomerase II,” Molecular and Biochemical Parasitology, vol. 55, no. 1-2, pp. 127–134, 1992. View at Publisher · View at Google Scholar · View at Scopus
  130. T. Hanke, M. J. Ramiro, S. Trigueros, J. Roca, and V. Larraga, “Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs,” Nucleic Acids Research, vol. 31, no. 16, pp. 4917–4928, 2003. View at Publisher · View at Google Scholar · View at Scopus
  131. A. L. Bodley and T. A. Shapiro, “Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 9, pp. 3726–3730, 1995. View at Google Scholar · View at Scopus
  132. B. B. Das, T. Sengupta, A. Ganguly, and H. K. Majumder, “Topoisomerases of kinetoplastid parasites: why so fascinating?” Molecular Microbiology, vol. 62, no. 4, pp. 917–927, 2006. View at Publisher · View at Google Scholar · View at Scopus
  133. N. Sen, B. B. Das, A. Ganguly, T. Mukherjee, S. Bandyopadhyay, and H. K. Majumder, “Camptothecin-induced imbalance in intracellular cation homeostasis regulates programmed cell death in unicellular hemoflagellate Leishmania donovani,” The Journal of Biological Chemistry, vol. 279, no. 50, pp. 52366–52375, 2004. View at Publisher · View at Google Scholar · View at Scopus
  134. N. Sen, B. Banerjee, B. B. Das et al., “Apoptosis is induced in leishmanial cells by a novel protein kinase inhibitor withaferin A and is facilitated by apoptotic topoisomerase I-DNA complex,” Cell Death & Differentiation, vol. 14, no. 2, pp. 358–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Roy, A. Ganguly, S. BoseDasgupta et al., “Mitochondria-dependent reactive oxygen species-mediated programmed cell death induced by 3,3′-diindolylmethane through inhibition of F0F1-ATP synthase in unicellular protozoan parasite Leishmania donovani,” Molecular Pharmacology, vol. 74, no. 5, pp. 1292–1307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. S. Chowdhury, T. Mukherjee, R. Mukhopadhyay et al., “The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice,” EMBO Molecular Medicine, vol. 4, no. 10, pp. 1126–1143, 2012. View at Google Scholar
  137. M. Gonzales-Perdomo, S. L. De Castro, M. N. S. L. Meirelles, and S. Goldenberg, “Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 9, pp. 1707–1714, 1990. View at Google Scholar · View at Scopus
  138. D. P. Cavalcanti, S. P. Fragoso, S. Goldenberg, W. de Souza, and M. C. M. Motta, “The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure,” Parasitology Research, vol. 94, no. 6, pp. 439–448, 2004. View at Publisher · View at Google Scholar · View at Scopus
  139. A. A. Zuma, D. P. Cavalcanti, M. C. P. Maia, W. de Souza, and M. C. M. Motta, “Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi,” International Journal of Antimicrobial Agents, vol. 37, no. 5, pp. 449–456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  140. J. C. F. Rodrigues, C. F. Bernardes, G. Visbal, J. A. Urbina, A. E. Vercesi, and W. de Souza, “Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition,” Protist, vol. 158, no. 4, pp. 447–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  141. P. Mukherjee, S. B. Majee, S. Ghosh, and B. Hazra, “Apoptosis-like death in Leishmania donovani promastigotes induced by diospyrin and its ethanolamine derivative,” International Journal of Antimicrobial Agents, vol. 34, no. 6, pp. 596–601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. A. E. Vercesi and R. Docampo, “Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ,” Biochemical Journal, vol. 284, no. 2, pp. 463–467, 1992. View at Google Scholar · View at Scopus
  143. A. Mukherjee, P. K. Padmanabhan, M. H. Sahani, M. P. Barrett, and R. Madhubala, “Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani,” Molecular and Biochemical Parasitology, vol. 145, no. 1, pp. 1–10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  144. J. Román Luque-Ortega, P. Reuther, L. Rivas, and C. Dardonville, “New benzophenone-derived bisphosphonium salts as leishmanicidal leads targeting mitochondria through inhibition of respiratory complex II,” Journal of Medicinal Chemistry, vol. 53, no. 4, pp. 1788–1798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  145. L. Carvalho, J. R. Luque-Ortega, C. López-Martín, S. Castanys, L. Rivas, and F. Gamarro, “The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 9, pp. 4204–4210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  146. J. R. Luque-Ortega and L. Rivas, “Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 4, pp. 1327–1332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. L. Carvalho, J. R. Luque-Ortega, J. I. Manzano, S. Castanys, L. Rivas, and F. Gamarro, “Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 12, pp. 5344–5351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Nihei, Y. Fukai, and K. Kita, “Trypanosome alternative oxidase as a target of chemotherapy,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1587, no. 2-3, pp. 234–239, 2002. View at Publisher · View at Google Scholar · View at Scopus
  149. Y. Yabu, T. Suzuki, C.-I. Nihei et al., “Chemotherapeutic efficacy of ascofuranone in Trypanosoma vivax-infected mice without glycerol,” Parasitology International, vol. 55, no. 1, pp. 39–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  150. K. Stuart and A. K. Panigrahi, “RNA editing: complexity and complications,” Molecular Microbiology, vol. 45, no. 3, pp. 591–596, 2002. View at Publisher · View at Google Scholar · View at Scopus
  151. K. S. Kim, S. M. R. Teixeira, L. V. Kirchhoff, and J. E. Donelson, “Transcription and editing of cytochrome oxidase II RNAs in Trypanosoma cruzi,” The Journal of Biological Chemistry, vol. 269, no. 2, pp. 1206–1211, 1994. View at Google Scholar · View at Scopus
  152. L. S. Paes, B. S. Mantilla, M. J. Barisón, C. Wrenger, and A. M. Silber, “The uniqueness of the trypanosoma cruzi mitochondrion: opportunities to target new drugs against chagaś disease,” Current Pharmaceutical Design, vol. 17, no. 20, pp. 2074–2099, 2011. View at Publisher · View at Google Scholar · View at Scopus
  153. S. Liang and G. J. Connell, “Identification of specific inhibitors for a trypanosomatid RNA editing reaction,” RNA, vol. 16, no. 12, pp. 2435–2441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  154. J. D. Durrant, L. Hall, R. V. Swift, M. Landon, A. Schnaufer, and R. E. Amaro, “Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1,” PLoS Neglected Tropical Diseases, vol. 4, no. 8, article e803, 2010. View at Publisher · View at Google Scholar · View at Scopus